期刊文献+

2013年美国放射肿瘤学会年会肝脏肿瘤放射治疗研究进展荟萃 被引量:1

Research progress in radiotherapy for liver tumors reported in 2013 ASTRO Annual Meeting
下载PDF
导出
摘要 随着放射治疗技术的进步,肝脏肿瘤放射治疗疗效的提高,放射治疗为不能手术治疗的患者提供了新的选择。介绍了2013年第55届美国放射肿瘤学会(ASTRO)关于肝脏肿瘤放射治疗方面的进展,主要为立体定向放射治疗(SBRT)治疗肝肿瘤的疗效及毒副作用。未来放射治疗在肝脏肿瘤治疗中的地位将会日益凸显。现将本届会议的主要研究报道分类整理如下。 With the development of radiotherapy techniques, the efficacy of radiotherapy for liver tumors has been improved, and radiotherapy can be considered as an alternative treatment for patients who are not suitable for surgery. The progress in liver tumor radiotherapy reported in the 55th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in 2013, particularly the efficacy and safety of stereotaetie body radiation therapy for liver tumors, is reviewed. In the future, radiotherapy may be increasingly used as an effective method in the treatment of liver tumors. The main studies reported at the meeting are sorted as follows in this article.
出处 《临床肝胆病杂志》 CAS 2014年第4期383-384,I0001,共3页 Journal of Clinical Hepatology
关键词 肝肿瘤 放射疗法 美国 综述 liver neoplasms radiotherapy United States review
  • 相关文献

参考文献9

  • 1STENMARK MH, CAO Y, WANG H, et al. Indocyanine green for individualized assessment of functional liver reserve in patients undergoing liver radiation therapy[J]. I ntJ Radiat Oncol Bioi Phys, 2013, 87(SuppI2): s26 -s27.
  • 2FENG MU, SCHIPPER MJ , BALTERJM, et al. A phase 2 trial of individualized adaptive stereotactic body radiation therapy (SBRT) for patients at high risk for liver damage[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87 ( Suppl 2) : s27.
  • 3SANUKI N. Stereotactic ablative body radiation therapy for small hepatocellular carcinoma: outcomes in 185 patients[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87 (Suppl 2) : s321.
  • 4QUEJ. The efficacy of stereotactic body radiation therapy for un resectable huge hepatocellular carcinoma not eligible for other local modalities[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87(SuppI2): s316.
  • 5MAHADEVAN A, CURRY M, LAKE - BAKAAR B, et al. Stereotactic body radiation therapy for unresectable large and multi- pie hepatocellular carcinoma[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87(SuppI2): s319 -s320.
  • 6BLACKSBURG SR, ZHANG E, LI UJ, et al. Combined transarterial chemoembolization(TACE) and stereotactic body radiation therapy ( SBRT) for management of primary hepatocellular carcinoma (HCC)[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87 (Suppl 2): s319.
  • 7GOODMAN B, CALLEY C, MALUCCIO M, et al. Survival efficacy following stereotactic body radiation therapy for limited liver metastases[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87 {Suppl Z}, s190.
  • 8YAMASHITA H, HIROSHI 0, YASUO M, et at, Comparison between stereotactic body radiation therapy for liver metastases and hepatocellular carcinoma[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87(SuppI2): s321.
  • 9MANNINA EM, LASLEY FD, CALLEY C, et al. Role of stereotactic body radiation therapy as a bridge to orthotopic liver transplantation: evaluation of pathological response and outcome[J]. IntJ Radiat Oncol Bioi Phys, 2013, 87 ( Suppl 2) : s323 -s324.

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部